Johnson & Johnson's $5.5 Billion Settlement Over Talc Lawsuits Claiming Ovarian Cancer
· Telemundo McAllen (KTLM)
Johnson & Johnson has agreed to a $5.5 billion settlement to resolve remaining lawsuits claiming its talc products caused ovarian cancer. The agreement requires participation from at least 95% of the remaining claimants. Last year, a bankruptcy judge rejected a proposed $9 billion settlement from the company's subsidiary, Red River Talc. A federal judge recently ordered claimants to justify why their pending talc claims should not be dismissed, as witnesses failed to establish a direct link between the product and cancer. Johnson & Johnson plans an initial payment of up to $3 billion next year, with no further payments until 2028.
AI summary · Source: Telemundo McAllen (KTLM) →
